DK1061955T3 - Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf - Google Patents

Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf

Info

Publication number
DK1061955T3
DK1061955T3 DK99912502T DK99912502T DK1061955T3 DK 1061955 T3 DK1061955 T3 DK 1061955T3 DK 99912502 T DK99912502 T DK 99912502T DK 99912502 T DK99912502 T DK 99912502T DK 1061955 T3 DK1061955 T3 DK 1061955T3
Authority
DK
Denmark
Prior art keywords
preparation
polynucleotide composition
polynucleotide
composition
Prior art date
Application number
DK99912502T
Other languages
English (en)
Inventor
Shankar Musunuri
Patrick P Deluca
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Priority claimed from EP99912502A external-priority patent/EP1061955B1/en
Application granted granted Critical
Publication of DK1061955T3 publication Critical patent/DK1061955T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0091—Purification or manufacturing processes for gene therapy compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0008—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'non-active' part of the composition delivered, e.g. wherein such 'non-active' part is not delivered simultaneously with the 'active' part of the composition

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Manufacturing & Machinery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK99912502T 1998-03-13 1999-03-12 Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf DK1061955T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7808098P 1998-03-13 1998-03-13
EP99912502A EP1061955B1 (en) 1998-03-13 1999-03-12 Polynucleotide composition, method of preparation, and use thereof
PCT/US1999/005547 WO1999045966A1 (en) 1998-03-13 1999-03-12 Polynucleotide composition, method of preparation, and use thereof

Publications (1)

Publication Number Publication Date
DK1061955T3 true DK1061955T3 (da) 2005-07-04

Family

ID=34621595

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99912502T DK1061955T3 (da) 1998-03-13 1999-03-12 Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf

Country Status (2)

Country Link
EP (1) EP1555033A3 (da)
DK (1) DK1061955T3 (da)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005113147A2 (en) 2004-04-08 2005-12-01 Biomatrica, Inc. Integration of sample storage and sample management for life science
JP5579164B2 (ja) 2008-04-09 2014-08-27 ビロメッド カンパニー， リミテッド 凍結乾燥ｄｎａ製剤、組成物、及び凍結乾燥ｄｎａ製剤を製造する方法
EP2598660B1 (en) 2010-07-26 2017-03-15 Biomatrica, INC. Compositions for stabilizing dna, rna and proteins in blood and other biological samples during shipping and storage at ambient temperatures
WO2012018639A2 (en) 2010-07-26 2012-02-09 Biomatrica, Inc. Compositions for stabilizing dna, rna and proteins in saliva and other biological samples during shipping and storage at ambient temperatures
US9725703B2 (en) 2012-12-20 2017-08-08 Biomatrica, Inc. Formulations and methods for stabilizing PCR reagents
US10639351B2 (en) 2013-10-22 2020-05-05 Helixmith Co., Ltd. Method for treating amyotrophic lateral sclerosis with a polynucleotide encoding two or more isoforms of hepatocyte growth factor
ES2786373T3 (es) 2014-06-10 2020-10-09 Biomatrica Inc Estabilización de trombocitos a temperaturas ambiente
KR20250047404A (ko) 2015-12-08 2025-04-03 바이오매트리카 인코포레이티드 적혈구 침강 속도의 감소
KR20210027493A (ko) 2018-07-19 2021-03-10 주식회사 헬릭스미스 네이키드 dna 유전자 요법을 위한 동결 건조된 약제학적 조성물

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2309692A (en) * 1991-07-03 1993-02-11 Cryolife, Inc. Method for stabilization of biomaterials
AU2215995A (en) * 1994-04-07 1995-10-30 Akzo Nobel N.V. Freeze-dried compositions comprising rna
WO1996027393A1 (en) * 1995-03-07 1996-09-12 University Of Pittsburgh A dry powder formulation for gene therapy
US5811406A (en) * 1995-06-07 1998-09-22 Regents Of The University Of California Dry powder formulations of polynucleotide complexes
JP4386965B2 (ja) * 1996-04-26 2009-12-16 メルク エンド カンパニー インコーポレーテッド Ｄｎａワクチン製剤
DE19716154A1 (de) * 1997-04-18 1998-10-22 Boehringer Mannheim Gmbh Stabile pharmazeutische Darreichungsform für Peptide, Proteine und Nukleinsäuren

Also Published As

Publication number Publication date
EP1555033A2 (en) 2005-07-20
EP1555033A3 (en) 2005-08-17

Similar Documents

Publication Publication Date Title
NO20012158D0 (no) Substituerte 2-fenylbenzimidazoler, fremgangsmåte til fremstilling og anvendelse derav
NO20013393L (no) Bronnsementeringsfremgangsmater og sammensetninger
DK1339292T3 (da) Sammensætning og fremgangsmåde
IL136951A0 (en) Sustained-release composition, method of its production and use thereof
NO20000602L (no) Krembasert matsammensetning og fremgangsmåte for fremstilling derav
DK1112003T3 (da) Ny sammensætning og anvendelse
NO20006488D0 (no) Sammensetning og anvendelse
DK0813873T3 (da) Farmaceutisk sammensætning omfattende mirtazapin og en eller flere selektive serotingenoptagelseshæmmere
DK1112174T3 (da) Isosorbidholdige polyestere og fremgangsmåder til fremstiling heraf
DK0926952T3 (da) Antimikrobiel sammensætning og fremgangsmåde til fremstilling deraf
DK1073672T3 (da) Antipicornavirale forbindelser, deres fremstilling og anvendelse
NO20005990L (no) Platinumkompleks, dets fremstilling og terapeutiske anvendelse
EE200100653A (et) Indolüülpiperidiinühendid, nende valmistamismeetod, kompositsioon ja nende kasutamine
FI981506A0 (fi) Elastomeerikompositio ja sen valmistusmenetelmä
NO20012963D0 (no) Fremgangsmåte for fremstilling av 3-alkanoylindoler og 3- alkylindoler
EE200100314A (et) Meetod farmatseutilise kompositsiooni valmistamiseks, farmatseutiline kompositsioon ja selle kasutamine
DK1061955T3 (da) Polynukleotidsammensætning, fremstillingsmetode og anvendelse deraf
DK0791591T3 (da) Benzothiophener, formuleringer indeholdende samme og fremgangsmåder til deres fremstilling
DK1140952T3 (da) Phosphororganiske forbindelser og anvendelse heraf
NO20005919L (no) Platinakompleks, dets fremstilling og terapeutisk anvendelse
NO990913L (no) Naftylforbindelser, intermediater, sammensetninger og metoder for anvendelse
PL337106A1 (en) Novel tetrahydronaphtalenes, method of obtaining them ,their application and aromatising composition containing them
NO20003268L (no) Hyperhydrert kitikolin, fremgangsmÕte og anvendelse
NO20006479D0 (no) Tienopyridinforbindelser, deres fremstilling og anvendelse
DK1046719T3 (da) D-galactosesammensætning og fremgangsmåde til fremstilling deraf